Published in Genome Med on March 30, 2016
Targeting neoantigens to augment antitumour immunity. Nat Rev Cancer (2017) 0.81
Pan-Specific Prediction of Peptide-MHC Class I Complex Stability, a Correlate of T Cell Immunogenicity. J Immunol (2016) 0.79
The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine Design. Front Immunol (2017) 0.77
Unconventional Peptide Presentation by Major Histocompatibility Complex (MHC) Class I Allele HLA-A*02:01: BREAKING CONFINEMENT. J Biol Chem (2017) 0.75
Analysis of nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-reactive CD8(+) T cell responses in children with NPM-ALK(+) anaplastic large cell lymphoma. Clin Exp Immunol (2016) 0.75
Simultaneous evolutionary expansion and constraint of genomic heterogeneity in multifocal lung cancer. Nat Commun (2017) 0.75
Machine Learning Reveals a Non-Canonical Mode of Peptide Binding to MHC class II Molecules. Immunology (2017) 0.75
ImmunoNodes - graphical development of complex immunoinformatics workflows. BMC Bioinformatics (2017) 0.75
Structural Definition of Duck Major Histocompatibility Complex Class I Molecules That Might Explain Efficient Cytotoxic T Lymphocyte Immunity to Influenza A Virus. J Virol (2017) 0.75
A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma. Oncoimmunology (2017) 0.75
In silico and cell-based analyses reveal strong divergence between prediction and observation of T cell recognized tumor antigen T cell epitopes. J Biol Chem (2017) 0.75
Prediction and in vitro verification of potential CTL epitopes conserved among PRRSV-2 strains. Immunogenetics (2017) 0.75
Sarcoma eradication by doxorubicin and targeted TNF relies upon CD8+ T cell recognition of a retroviral antigen. Cancer Res (2017) 0.75
SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics (1999) 14.15
Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu Rev Immunol (1999) 7.18
Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci (2003) 5.94
NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11. Nucleic Acids Res (2008) 4.53
NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence. PLoS One (2007) 3.99
NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics (2008) 3.59
Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method. BMC Bioinformatics (2005) 2.91
Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method. BMC Bioinformatics (2007) 2.83
Accurate approximation method for prediction of class I MHC affinities for peptides of length 8, 10 and 11 using prediction tools trained on 9mers. Bioinformatics (2008) 2.69
The IPD and IMGT/HLA database: allele variant databases. Nucleic Acids Res (2014) 2.66
The immune epitope database (IEDB) 3.0. Nucleic Acids Res (2014) 2.50
NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction. BMC Bioinformatics (2009) 2.50
NetMHCIIpan-2.0 - Improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure. Immunome Res (2010) 1.78
NetMHCcons: a consensus method for the major histocompatibility complex class I predictions. Immunogenetics (2011) 1.57
NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ. Immunogenetics (2013) 1.49
HLA class I alleles are associated with peptide-binding repertoires of different size, affinity, and immunogenicity. J Immunol (2013) 1.32
A comparative study of HLA binding affinity and ligand diversity: implications for generating immunodominant CD8+ T cell responses. J Immunol (2009) 1.30
Three-dimensional structure of a peptide extending from one end of a class I MHC binding site. Nature (1994) 1.26
Derivation of an amino acid similarity matrix for peptide: MHC binding and its application as a Bayesian prior. BMC Bioinformatics (2009) 1.23
NNAlign: a web-based prediction method allowing non-expert end-user discovery of sequence motifs in quantitative peptide data. PLoS One (2011) 1.20
Gapped sequence alignment using artificial neural networks: application to the MHC class I system. Bioinformatics (2015) 1.18
HLArestrictor--a tool for patient-specific predictions of HLA restriction elements and optimal epitopes within peptides. Immunogenetics (2010) 1.11
Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification. Immunogenetics (2015) 0.93
Automated benchmarking of peptide-MHC class I binding predictions. Bioinformatics (2015) 0.92
Preferred size of peptides that bind to H-2 Kb is sequence dependent. Eur J Immunol (1992) 0.90
HLA peptide length preferences control CD8+ T cell responses. J Immunol (2013) 0.90
Dataset size and composition impact the reliability of performance benchmarks for peptide-MHC binding predictions. BMC Bioinformatics (2014) 0.85
Defining the HLA class I-associated viral antigen repertoire from HIV-1-infected human cells. Eur J Immunol (2015) 0.83
Tapasin facilitation of natural HLA-A and -B allomorphs is strongly influenced by peptide length, depends on stability, and separates closely related allomorphs. J Immunol (2013) 0.83
Identification and characterisation of peptide binding motifs of six autoimmune disease-associated human leukocyte antigen-class I molecules including HLA-B*39:06. Tissue Antigens (2014) 0.80
Machine Learning Reveals a Non-Canonical Mode of Peptide Binding to MHC class II Molecules. Immunology (2017) 0.75